This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.
Dr. Graziele Moraes Losso, director of the Molecular Biology division at Mantis Advanced Diagnostics Laboratory, will share the validation and comparison process her team used to help them smoothly migrate from real-time PCR and pyrosequencing to NGS testing. Dr. Losso will show some of her lab’s results working with somatic cancer testing using the GeneReader NGS System with different sample types (blood; formalin-fixed, paraffin-embedded; and liquid biopsies), and their performance in the European Molecular Genetics Quality Network (EMQN).
Dr. Losso will also discuss a case study with demonstrates the importance of having high quality NGS analysis and evidence-based interpretation when determining the actionability of test sample data.
For Research Use Only. Not for use in diagnostic procedures.